160 related articles for article (PubMed ID: 1287140)
1. Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patients.
Barchiesi F; Giacometti A; Arzeni D; Branchesi P; Crescenzi G; Ancarani F; Scalise G
J Chemother; 1992 Dec; 4(6):381-6. PubMed ID: 1287140
[TBL] [Abstract][Full Text] [Related]
2. Comparison of itraconazole and ketoconazole in HIV-positive patients with oropharyngeal or esophageal candidiasis. Human Immunodeficiency Virus Itraconazole Ketoconazole Project Group.
de Repentigny L; Ratelle J
Chemotherapy; 1996; 42(5):374-83. PubMed ID: 8874977
[TBL] [Abstract][Full Text] [Related]
3. Rationalizing prescribing for oral and oesophageal candidiasis.
Taylor CB; Finlay R; Richardson C; Bunting P; Welch J
Int J STD AIDS; 1996 Oct; 7(6):452. PubMed ID: 8940678
[No Abstract] [Full Text] [Related]
4. [Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS].
Tebbe B; Boyvat A; Geilen CC; Wölfer LU; Seibold M; Orfanos CE
Hautarzt; 1996 Feb; 47(2):136-9. PubMed ID: 8868459
[TBL] [Abstract][Full Text] [Related]
5. Fluconazole versus ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children. Multicentre Study Group.
Hernández-Sampelayo T
Eur J Clin Microbiol Infect Dis; 1994 Apr; 13(4):340-4. PubMed ID: 8070443
[TBL] [Abstract][Full Text] [Related]
6. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest].
Tapia C; González P; Pereira A; Pérez J; Noriega LM; Palavecino E
Rev Med Chil; 2003 May; 131(5):515-9. PubMed ID: 12879812
[TBL] [Abstract][Full Text] [Related]
7. Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection.
Skiest DJ; Vazquez JA; Anstead GM; Graybill JR; Reynes J; Ward D; Hare R; Boparai N; Isaacs R
Clin Infect Dis; 2007 Feb; 44(4):607-14. PubMed ID: 17243069
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
Samaranayake YH; Samaranayake LP; Tsang PC; Wong KH; Yeung KW
J Oral Pathol Med; 2001 Jul; 30(6):336-46. PubMed ID: 11459319
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis, treatment and prevention of infections caused by fungi in HIV-positive patients].
Fortun Abete J
Rev Clin Esp; 1995 Oct; 195 Suppl 3():4-14. PubMed ID: 9441305
[No Abstract] [Full Text] [Related]
10. [Oro-esophageal candidiasis resistant to fluconazole in patients with AIDS].
Diz P; Ocampo A; Miralles C; Otero I; Iglesias I; Martínez C
Enferm Infecc Microbiol Clin; 1993 Jan; 11(1):36-9. PubMed ID: 8461371
[TBL] [Abstract][Full Text] [Related]
11. A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.
Vazquez JA; Skiest DJ; Nieto L; Northland R; Sanne I; Gogate J; Greaves W; Isaacs R
Clin Infect Dis; 2006 Apr; 42(8):1179-86. PubMed ID: 16575739
[TBL] [Abstract][Full Text] [Related]
12. Clinical predictors of azole resistance, outcome and survival from oesophageal candidiasis in AIDS patients.
Laing RB; Brettle RP; Leen CL
Int J STD AIDS; 1998 Jan; 9(1):16-20. PubMed ID: 9518009
[TBL] [Abstract][Full Text] [Related]
13. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection.
Tumbarello M; Caldarola G; Tacconelli E; Morace G; Posteraro B; Cauda R; Ortona L
J Antimicrob Chemother; 1996 Oct; 38(4):691-9. PubMed ID: 8937963
[TBL] [Abstract][Full Text] [Related]
15. Fluconazole-resistant Candida in AIDS patients. Report of two cases.
Heinic GS; Stevens DA; Greenspan D; MacPhail LA; Dodd CL; Stringari S; Strull WM; Hollander H
Oral Surg Oral Med Oral Pathol; 1993 Dec; 76(6):711-5. PubMed ID: 8284074
[TBL] [Abstract][Full Text] [Related]
16. [Itraconazole suspension in the treatment of HIV-infected patients with fluconazole-resistant oropharyngeal candidiasis and esophagitis].
Eichel M; Just-Nübling G; Helm EB; Stille W
Mycoses; 1996; 39 Suppl 1():102-6. PubMed ID: 8767280
[TBL] [Abstract][Full Text] [Related]
17. Fluconazole for ketoconazole-resistant oropharyngeal candidiasis in HIV-1 infected patients.
Thorsen S; Mathiesen LR
Scand J Infect Dis; 1990; 22(3):375-6. PubMed ID: 2371551
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of candidiasis and cryptococcosis in AIDS].
Just-Nübling G
Mycoses; 1994; 37 Suppl 2():56-63. PubMed ID: 7609745
[TBL] [Abstract][Full Text] [Related]
19. Candidiasis.
Powderly WG
J Int Assoc Physicians AIDS Care; 1996 Oct; 2(10):36-9. PubMed ID: 11363911
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients.
de Wet N; Llanos-Cuentas A; Suleiman J; Baraldi E; Krantz EF; Della Negra M; Diekmann-Berndt H
Clin Infect Dis; 2004 Sep; 39(6):842-9. PubMed ID: 15472817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
